Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Bayer HealthCare AG

Division of Bayer AG
www.bayerhealthcare.com

Latest From Bayer HealthCare AG

Starboard-Driven Perrigo Sees CEO Depart After CFO

Perrigo's CEO John Hendrickson, who was appointed to the post when Joseph Papa left to head Valeant in 2016, is to retire. The company is also looking for a permanent CFO after Judy Brown left in February. The departures follow a board shake-up pushed through by activist investor Starboard Value LP.

Leadership Business Strategies

US FDA's Gottlieb Wants Safety Built Into New Medtech Products, But Budget Will Be Cut To Surveil Older Ones

President Trump's proposed budget cuts to the agency's post-market surveillance programs means that more "faulty" devices, such as St. Jude defibrillators and Bayer HealthCare's Essure birth control coils, will cause harm rather than be recalled, Rep. Rosa DeLauro said at a May 25 House Ag/FDA subpanel hearing. FDA Commissioner Scott Gottlieb told DeLauro the agency needs to supply "the right tools" to firms during device development so similarly flawed devices aren't put on the market, and he noted that the lifting of a hiring freeze at the agency earlier in the day would free the agency to work harder on such issues.

Policy & Regulation Legislation

Aiming To Lead A Global Operation? Start In China!

Moving from China president to a CEO, from regional Asia head to a global pharmaceutical president, several recent senior executive appointments have people wondering if China is increasingly becoming the new launch pad for high flyers eyeing a global pharma leadership role.

Appointments Strategy

Boehringer Targets Hearing Loss In First China Pharma R&D collaboration

Joining a growing number of its multinational peers tapping into China’s expanding innovative capabilities, Boehringer Ingelheim has teamed up with an academic research group to develop novel stem cell therapies for hearing loss, further encouraged by new state support for regenerative medicine.

China Research and Development Strategies
See All

Company Information

  • Industry
  • In Vitro Diagnostics
  • Pharmaceuticals
  • Therapeutic Areas
  • Non-Specific
  • Alias(es)
  • Ownership
  • Private
  • Headquarters
  • Worldwide
    • Europe
      • Western Europe
        • Germany
  • Parent & Subsidiaries
  • Bayer AG
  • Senior Management
  • Olivier Brandicourt, MD, CEO
  • Contact Info
  • Bayer HealthCare AG
    Phone: (49) 214-30-81013
    Building Q 30
    Leverkusen, 51368
    Germany
Advertisement
Advertisement
UsernamePublicRestriction

Register